Federal and Other Funding Opportunities

Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding

Search for all currently funded medical rehabilitation research opportunities on Grants.gov.

Central and Peripheral Control of Balance in Older Adults (R01 Clinical Trial Optional)
(RFA-AG-21-011) National Institute on Aging and National Institute on Deafness and Other Communication Disorders
Application Receipt Date: October 2, 2020

NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)|
(PAR-20-084) National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): Application Receipt Date(s): Standard dates apply.

NCMRR Early Career Research Award (R03 Clinical Trial Optional)
(PAR-20-042) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Application Due Date(s): March 30, 2020, March 30, 2021, March 30, 2022

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)
(RFA-NS-20-011) Multiple Institutes
Application Receipt Date(s): January 8, 2020; April 7, 2020; September 9, 2020; January 6, 2021; April 6, 2021; September 8, 2021; January 6, 2022; April 6, 2022; and September 8, 2022

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)
(RFA-NS-20-010) Multiple Institutes
Application Receipt Date(s): January 8, 2020; April 7, 2020; September 9, 2020; January 6, 2021; April 6, 2021; September 8, 2021; January 6, 2022; April 6, 2022; and September 8, 2022

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
(RFA-NS-20-009) Multiple Institutes
Application Receipt Date(s): January 8, 2020; April 7, 2020; September 9, 2020; January 6, 2021; April 6, 2021; September 8, 2021; January 6, 2022; April 6, 2022; and September 8, 2022

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)
(RFA-NS-20-008) Multiple Institutes
Application Receipt Date(s): January 8, 2020; April 7, 2020; September 9, 2020; January 6, 2021; April 6, 2021; September 8, 2021; January 6, 2022; April 6, 2022; and September 8, 2022

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)
(PAR-19-355) National Cancer Institute
Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 16, 2019.  

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)
(PAR-19-352) National Cancer Institute
Application Receipt Date(s): October 17, 2019; then standard dates apply. The first standard due date for this FOA is February 5, 2020.

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
(PAR-19-376) Multiple Institutes
Application Receipt Date(s): November 19, 2019; September 24, 2020